Gufic Biosciences has scheduled its 42nd Annual General Meeting (AGM) for Friday, September 4, 2026, at 3:30 pm. The meeting will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM), in compliance with Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI) circulars permitting virtual meetings without physical presence.

Key Agenda Items

The primary business to be transacted includes the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. The Board has recommended a final dividend of ₹0.10 per equity share of face value ₹1 each for FY26. This payout is subject to approval by shareholders at the AGM.

Additionally, the meeting will address special business resolutions regarding board appointments and auditor remuneration:

• Re-appointment of Whole Time Director: Shareholders will vote on the re-appointment of Mr. Pankaj J. Gandhi (DIN: 00001858) as Whole Time Director for a further term of five years, commencing September 7, 2026, and ending September 6, 2031. The resolution also seeks approval for his continuation in office beyond the age of 70 years, which he will attain during this tenure. His annual salary is capped at ₹1 crore, inclusive of increments, along with standard perquisites and allowances.
• Cost Auditor Remuneration: The Board proposes ratifying the remuneration of M/s. Poddar & Co. (FRN: 101734) as Cost Auditors for FY27. The approved fee is ₹4 lakh per annum plus applicable taxes and reimbursement of actual out-of-pocket expenses.
• Director Retirement by Rotation: Mr. Pranav J. Choksi (DIN: 00001731), son of Chairman & Managing Director Mr. Jayesh P. Choksi, retires by rotation and offers himself for re-appointment.

Book Closure and Record Date

The Register of Members and Share Transfer Books will remain closed from Saturday, August 29, 2026, to Friday, September 4, 2026, both days inclusive. This closure facilitates the determination of shareholders eligible for the AGM and the payment of the final dividend for FY26.

Voting and Participation

The company is providing remote e-voting facilities through National Securities Depository Limited (NSDL). The remote e-voting period commences on Tuesday, September 1, 2026, at 9:00 am and ends on Thursday, September 3, 2026, at 5:00 pm. Only members holding shares as on the record date are eligible to vote. The facility for appointing proxies has been dispensed with due to the virtual nature of the meeting.

What the Numbers Show

The proposed final dividend of ₹0.10 per share represents a 10% payout on the ₹1 face value. While the filing does not disclose total equity capital or prior-year dividend comparisons within this notice, the consistent recommendation of dividends indicates ongoing cash generation capability. The re-appointment of Mr. Gandhi, who holds no shares in the company, aligns executive retention with regulatory compliance rather than equity-based incentives.

Gufic Biosciences Limited will host an earnings conference call for investors and analysts on Monday, August 17, 2026, at 04:30 p.m. (IST). The session is intended to provide stakeholders with insights into the company's business background, future prospects, and recent financial performance. Officials from the company will also address questions from participants during the call. This disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company notified both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE) regarding the event. The intimation, signed by Ami Shah, Company Secretary & Compliance Officer, was issued on August 11, 2026. The notice ensures that market participants are aware of the upcoming discussion platform where management will elaborate on operational updates and financial outcomes.

Conference Call Details

Participants can join the earnings call via pre-registration or through dedicated dial-in numbers provided for various regions. The company has facilitated access for domestic and international investors by listing contact numbers for India, the United States, the United Kingdom, Singapore, and Hong Kong.

Investors are advised to use the pre-registration link provided in the official invitation to ensure seamless access to the virtual meeting platform. The call invite includes all necessary technical details for joining the session.

Regulatory Compliance

The announcement adheres to the mandatory disclosure norms set by the Securities and Exchange Board of India (SEBI). By hosting this conference call, Gufic Biosciences Limited fulfills its obligation to communicate material information to its shareholders and the investing public promptly. The Company Secretary confirmed the details with a digital signature dated August 11, 2026, ensuring the authenticity of the communication sent to the stock exchanges.